OncologyAPPAHOCANCT03473652
Feasibility of Adapted Physical Activity Based on a Walking Platform in Hospitalized Old Patients for Cancer
A study testing Adapted walking platform in people with Oncology and Adapted Physical Activity, run by Centre Francois Baclesse at 2 sites in France.
Trial summary
The investigator propose to evaluate the interest of the provision of a suitable treadmill offering fall protection and verticalization assistance. Read more about this study
- Who is it for?
- Ages 70 years and older
- Conditions the study is for
- Oncology, Adapted Physical Activity
- What is being tested?
- Adapted walking platform
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 45 participants
- Where
- 2 sitesFrance
- Study dates
- 29 May 2018to 11 Dec 2018
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 70 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- Patient with cancer
- Patient over 70 years old hospitalized 48 hours or more
- Patient identified as eligible for medical prescription of Adapted physical activity
- Mastery of the French language ;
- Patient affiliated to a social security scheme
- Patient giving written consent
Who cannot join
- Patient totally unable to communicate
- Patient in terminal palliative care
- Patient with a size <1m35 or> 2m and / or a weight> 130kg
- Patient unable to perform Adapted physical activity sessions
- Patient unable to wear a restraint harness.
- Patient deprived of liberty or under guardianship
- Patient unable to comply with protocol requirements for geographical, social or psychopathological reasons
Trial locations and contacts
2 sites in 1 country.
About this study
The investigator propose to evaluate the interest of the provision of a suitable treadmill offering fall protection and verticalization assistance.
- Conditions
- Oncology, Adapted Physical Activity
- Being tested
- Adapted walking platform
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Adapted walking platformOther
The walking sessions will be carried out on a suitable walking platform, including a connected play tablet.
| Study group | Role | What they receive |
|---|---|---|
| Adapted walking platform | Other | Not described Receives: Other: Adapted walking platform |
What is being measured
The primary outcome is the main question the study is designed to answer.
Patient Adherence to Use a Walking Platform
Adapted physical activity on a walking platform will be considered feasible if > or = to 70% of patients perform > or = to 2 sessions of 6 minutes or more during hospitalization for cancer lasting > or = to 48h
Measured: 2 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Mar 2018
- Study start29 May 2018
- Primary completion11 Oct 2018
- Study completion11 Dec 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for OncologyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 45 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Francois Baclesse
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03473652
- Sponsor's protocol ID
- APPAHOCA
- Acronym
- APPAHOCA
- Status last verified
- Nov 2025
- First submitted
- 12 Mar 2018
- Last updated
- 15 Dec 2025
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility of Adapted Physical Activity Based on a Walking Platform in Hospitalized Old Patients for Cancer
- ClinicalTrials.gov ID
- NCT03473652
- Acronym / sponsor ID
- APPAHOCA / APPAHOCA
- Conditions
- Oncology, Adapted Physical Activity
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 45 participants (actual)
- Lead sponsor
- Centre Francois BaclesseUniversity, hospital or other
- Study start
- 29 May 2018 (actual)
- Primary completion
- 11 Oct 2018 (actual)
- Study completion
- 11 Dec 2018 (actual)
- First posted
- 22 Mar 2018 (actual)
- Results
- Posted 15 Dec 2025
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The investigator propose to evaluate the interest of the provision of a suitable treadmill offering fall protection and verticalization assistance.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Adapted walking platform | Other | Other: Adapted walking platform |
Who may qualify
- Ages
- 70 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (6 listed)
- Patient with cancer
- Patient over 70 years old hospitalized 48 hours or more
- Patient identified as eligible for medical prescription of Adapted physical activity
- Mastery of the French language ;
- Patient affiliated to a social security scheme
Key exclusion criteria (7 listed)
- Patient totally unable to communicate
- Patient in terminal palliative care
- Patient with a size <1m35 or> 2m and / or a weight> 130kg
- Patient unable to perform Adapted physical activity sessions
- Patient unable to wear a restraint harness.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Adapted walking platformThe walking sessions will be carried out on a suitable walking platform, including a connected play tablet. | Other | Adapted walking platform |
Primary outcome
Patient Adherence to Use a Walking Platform
Time frame: 2 days
Adapted physical activity on a walking platform will be considered feasible if > or = to 70% of patients perform > or = to 2 sessions of 6 minutes or more during hospitalization for cancer lasting > or = to 48h
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Dec 2025.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: No
Related trials for Oncology
RecruitingPhase 4
Evaluating the Safety of Shortened Infusion Times for dIfferent Oncological Immunotherapie
Oncology, Infusion Reaction
Recruiting
Swiss 2024 Continous Fever Monitoring in Pediatric Oncology Patients
Pediatric Oncology Patients With Risk for Infections
RecruitingObservational study
Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally Advanced or Metastatic NSCLC: A Multicenter, Prospective, Real-World Cohort Study
Patients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLC, EGFR Mutation-negative and ALK Rearrangement-negative
Enrolling by invitation
Clinical Alternatives for Reducing Harm Using E-cigarettes
Smoking, E-Cig Use
Recruiting
Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments
Sarcopenia, Oncology
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Adapted walking platform in people with Oncology and Adapted Physical Activity, run by Centre Francois Baclesse at 2 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 15 Dec 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patient Adherence to Use a Walking Platform (time frame: 2 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Dec 2025; AzTrials last refreshed its copy on 1 Nov 2026.